Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients

Abstract Background This study aimed to investigate the clinical utility of serum and histological MMP-9 detection during neoadjuvant chemotherapy (NAC) for triple-negative breast cancer (TNBC). Methods A total of 303 TNBC patients who underwent weekly paclitaxel plus carboplatin treatments followed...

Full description

Bibliographic Details
Main Authors: Ruo-Xi Wang, Sheng Chen, Liang Huang, Zhi-Ming Shao
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Cancer
Subjects:
Breast cancer
Neoadjuvant chemotherapy
MMP-9
Pathological response
Prognostic marker
Online Access:http://link.springer.com/article/10.1186/s12885-018-4822-7

Internet

http://link.springer.com/article/10.1186/s12885-018-4822-7

Similar Items